Yu Baofa

In this Chinese name, the family name is Yu.
Dr.
Yu Baofa
Born1958 (age 65–66)
Jinan, China
NationalityChinese
EducationBinzhou Medical College, Peking Union Medical College
OccupationOncologist
Medical career
ResearchIntratumoral Cancer Therapy
Notable worksUltra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.
Websitewww.baofatherapy.com

Yu Baofa (Chinese: 于保法; pinyin: Yú Bǎofǎ; born in 1958) is a Chinese oncologist and researcher in intratumoral cancer therapy and drug development.[1] He is the Founder, CEO and Chairman of Baofa Cancer Hospital Network China in Jinan, Beijing and Dongping.[2] He also developed Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.[3][4]

  1. ^ "Professor devoted to medical research and treatmentn". www.chinadaily.com.cn. Retrieved 3 March 2019.
  2. ^ "Meet Dr. Baofa Yu". Baofa Immunotherapy, LLC. Retrieved 3 March 2019.
  3. ^ Yu, Baofa; Lu, Yuanfei; Gao, Feng; Jing, Peng; Wei, Han; Zhang, Peicheng; Liu, Guoliang; Ru, Ning; Cui, Guanghui; Xu, Xinhai; Sun, Chenglin; Guan, Changjiang; Che, Yebing; Wu, Yingli; Ma, Zhenlu; Fu, Qiang; Liu, Jian; Wang, Huan-You (2015). "Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy". Lung Cancer: Targets and Therapy. 6: 1–11. doi:10.2147/LCTT.S70679. PMC 5217516. PMID 28210146.
  4. ^ Gao, Feng; Jing, Peng; Liu, Jian; Lu, Yuanfei; Zhang, Peicheng; Han, Wei; Liu, Guoliang; Ru, Ning; Cui, Guanghui; Sun, Chenglin; Che, Yebing; Zhang, Huaming; Hu, Qnglong; Wang, Huan-You; Wu, Yingli; Guan, Changjiang; Fu, Qiang; Ma, Zhenlu; Yu, Baofa (2015). "Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy". Journal of Hepatocellular Carcinoma. 2: 57–68. doi:10.2147/JHC.S80756. PMC 4918285. PMID 27508195.